Web Results


Abarelix (trade name Plenaxis) is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in oncology to reduce the ...


Apr 3, 2017 ... Learn about Plenaxis (Abarelix) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related ...


Jun 13, 2005 ... Name, Abarelix. Accession Number, DB00106 (BTD00051, BIOD00051). Type, Biotech. Groups, Approved, Investigational, Withdrawn.


Easy to read patient leaflet for abarelix. Includes indications, proper use, special instructions, precautions, and possible side effects.


Abarelix is a synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to ...


Abarelix reduces the amount of testosterone produced in the body. Abarelix is used in the palliative treatment of advanced prostate cancer. Abarelix may also be ...


Abarelix reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).


Plenaxis (abarelix for injectable suspension): For treatment of advanced prostate cancer. New approved drug details including side effects, uses and general ...


Abarelix for injectable suspension (Plenaxis™) is a synthetic decapeptide with potent ... The molecular weight for abarelix anhydrous free base is 1416.06.